Tech Company Financing Transactions
Inocras Funding Round
Inocras closed a $31 million Series B funding round on 8/3/2026. Investors included DSC Investment, Dunamu & Partners and IMM Investment.
Transaction Overview
Company Name
Announced On
8/3/2026
Transaction Type
Venture Equity
Amount
$31,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to expand its whole-genome sequencing and proprietary bioinformatics platform in the United States.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6330 Nancy Ridge Drive 106
?San Diego, CA 92121
USA
?San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
Founded in 2020 by a team of physician-scientists, geneticists, and bioinformaticians, our goal has been to improve how patients are diagnosed and treated by unlocking the full potential of genomic data. Since then, we've developed an IP-protected technology and proprietary whole genome insight platform while achieving operational excellence in our CLIA certified and CAP accredited lab.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jehee Suh
Chief Medical Officer
Erin Connolly-Strong
Chief Operating Officer
Stephanie Ferguson
Chief Technical Officer
Sangmoon Lee
Co-Founder
Young Ju
Co-Founder
Jeong Lee
VP - Bus. Development
Rebecca Jang
VP - Product Management
Brian Oh
Browse more venture capital transactions:
Prev: 8/3/2026: Wayy.ai venture capital transaction
Next: 8/3/2026: Blaze Technology venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs